MCID: PLX001
MIFTS: 37

Plexiform Schwannoma malady

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Plexiform Schwannoma

About this section

Aliases & Descriptions for Plexiform Schwannoma:

Name: Plexiform Schwannoma 11 13 68
Plexiform Neurilemmoma 11
 
Plexiform Neurinoma 11

Classifications:



External Ids:

Disease Ontology11 DOID:3206
NCIt45 C6969

Summaries for Plexiform Schwannoma

About this section
MalaCards based summary: Plexiform Schwannoma, also known as plexiform neurilemmoma, is related to esophagitis and watson syndrome. An important gene associated with Plexiform Schwannoma is NF2 (Neurofibromin 2), and among its related pathways are Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers and Neuroscience. Affiliated tissues include trachea, tongue and breast, and related mouse phenotypes are hearing/vestibular/ear and digestive/alimentary.

Related Diseases for Plexiform Schwannoma

About this section

Diseases related to Plexiform Schwannoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 127)
idRelated DiseaseScoreTop Affiliating Genes
1esophagitis28.2CD34, ENO2, NF1, NF2, NGFR
2watson syndrome10.6NF1, NF2
3ovarian disease10.5NF1, NF2
4conventional fibrosarcoma10.5NF1, NF2
5atypical neurofibroma10.5NF1, NF2
6bone lymphoma10.5NF1, NF2
7epilepsy, familial focal, with variable foci10.5NF1, NF2
8surfactant metabolism dysfunction, pulmonary, 510.5NF1, NF2
9gastric cardia carcinoma10.4DSP, KIT
10laryngeal disease10.4DSP, KIT
11retinal melanoma10.4B3GAT1, NF1
12petrous apex meningioma10.3ENO2, NF1
13chordoid glioma10.3GFAP, NF2
14skin glomus tumor10.3ENO2, KIT
15renal pelvis inverted papilloma10.3GFAP, NF2
16parotid gland adenoid cystic carcinoma10.3KIT, NGFR
17vagina leiomyosarcoma10.3ENO2, KIT
18external ear disease10.3GFAP, NF2
19cauda equina intradural extramedullary astrocytoma10.3GFAP, NF2
20non-congenital cyst of kidney10.3NF1, NF2
21prostate small cell carcinoma10.3ENO2, KIT
22capgras syndrome10.3B3GAT1, CDSN
23sphenoidal sinus cancer10.3ENO2, KIT
24localized pulmonary fibrosis10.3ENO2, KIT
25glomeruloid hemangioma10.3GFAP, NF1
26clear cell ependymoma10.3GFAP, NF2
27epithelioid leiomyosarcoma10.3ENO2, KIT
28pseudoglandular variant testicular seminoma10.3GFAP, NF1
29central centrifugal cicatricial alopecia10.2GFAP, NF2
30cerebrum cancer10.2B3GAT1, ENO2
31neurilemmoma of the fifth cranial nerve10.2GFAP, NF2
32in situ carcinoma10.2KIT, NF1, NF2
33ovarian clear cell malignant adenofibroma10.2B3GAT1, ENO2
34plexiform neurofibroma10.2CD34, DSP
3510.2CD34, NF2
36meningothelial meningioma10.2CD34, NF2
37lyme disease - neurological complications10.2ENO2, GFAP
38nonsyndromic congenital nail disorder 210.1ENO2, KIT
39childhood central nervous system primitive neuroectodermal neoplasm10.1ENO2, GFAP
40perivascular epithelioid cell tumor10.1GFAP, KIT
41expressive language disorder10.1ENO2, NF1, NF2
42xanthogranulomatous pyelonephritis10.1ENO2, NF1, NF2
43hypersensitivity reaction type ii disease10.1ENO2, GFAP
44trochlear nerve neoplasm10.1ENO2, NF1, NF2
45cardiac granular cell neoplasm10.1B3GAT1, ENO2
46sialolithiasis10.1GFAP, KIT
47subpulmonary stenosis10.1ENO2, GFAP
48brain stem ependymoma10.1ENO2, GFAP
49noninvasive malignant thymoma10.1DSP, GFAP, NF2
50myxoid leiomyosarcoma10.1CD34, KIT

Graphical network of the top 20 diseases related to Plexiform Schwannoma:



Diseases related to plexiform schwannoma

Symptoms & Phenotypes for Plexiform Schwannoma

About this section

MGI Mouse Phenotypes related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053779.7KIT, NF1, NF2, NGFR
2MP:00053819.1DSP, GFAP, KIT, NF1, NGFR
3MP:00053699.1DSP, GFAP, KIT, NF1, NGFR
4MP:00053828.9DSP, ENO2, KIT, NF1, NF2, NGFR
5MP:00107718.6CD34, DSP, KIT, NF1, NF2, NGFR
6MP:00053888.4ENO2, KIT, NF1, NF2, NGFR
7MP:00053868.1B3GAT1, ENO2, GFAP, KIT, NF1, NF2
8MP:00053847.8CD34, DSP, ENO2, GFAP, KIT, NF1
9MP:00036317.7B3GAT1, DSP, ENO2, GFAP, KIT, NF1

Drugs & Therapeutics for Plexiform Schwannoma

About this section

Drugs for Plexiform Schwannoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 2, Phase 3171423214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
IfosfamideapprovedPhase 2, Phase 33913778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
3
MechlorethamineapprovedPhase 2, Phase 337751-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
╬▓,╬▓'-dichlorodiethyl-N-methylamine
4
Cyclophosphamideapproved, investigationalPhase 2, Phase 3282950-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
5
DoxilApproved June 1999Phase 2, Phase 3171431703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
6Anti-Bacterial AgentsPhase 2, Phase 310884
7Topoisomerase InhibitorsPhase 2, Phase 34945
8Isophosphamide mustardPhase 2, Phase 3391
9Antibiotics, AntitubercularPhase 2, Phase 36972
10Antineoplastic Agents, AlkylatingPhase 2, Phase 34474
11Alkylating AgentsPhase 2, Phase 34694

Interventional clinical trials:

idNameStatusNCT IDPhase
1Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryRecruitingNCT02180867Phase 2, Phase 3
2Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in NeurofibromatosisUnknown statusNCT01777451
3Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1RecruitingNCT02211768Early Phase 1
4Natural History Study of Patients With Neurofibromatosis Type IRecruitingNCT00924196

Search NIH Clinical Center for Plexiform Schwannoma

Genetic Tests for Plexiform Schwannoma

About this section

Anatomical Context for Plexiform Schwannoma

About this section

MalaCards organs/tissues related to Plexiform Schwannoma:

36
Trachea, Tongue, Breast, Small intestine

Publications for Plexiform Schwannoma

About this section

Articles related to Plexiform Schwannoma:

(show top 50)    (show all 64)
idTitleAuthorsYear
1
Plexiform schwannoma of the thoracolumbar spine a rare clinical entity - a case report. (27809595)
2016
2
Congenital cellular plexiform schwannoma mimicking a vascular lesion: Potential pitfalls in clinical and histopathological assessment. (26728820)
2016
3
Plexiform schwannoma: an unusual clitoral mass. (27818132)
2016
4
Gastric plexiform schwannoma in association with neurofibromatosis type 2. (27696205)
2016
5
A rare case of plexiform schwannoma of the lower lip: Treatment and management. (26424990)
2015
6
Plexiform schwannoma of the posterior pharyngeal wall in a patient with neurofibromatosis 2. (25738721)
2015
7
Successful enucleation of large multinodular/plexiform schwannoma of the foot and ankle. (26090307)
2015
8
Plexiform Schwannoma of Lumbar Region. (26064806)
2015
9
Congenital cellular plexiform schwannoma mimicking a vascular lesion: Potential pitfalls in clinical and histopathological assessment. (26658391)
2015
10
Plexiform schwannoma involving the trachea and recurrent laryngeal nerve: a case report. (26366364)
2015
11
Oral plexiform schwannoma withA unusual epithelial induction. (26268670)
2015
12
Case presentations and review of plexiform schwannoma in the foot. (24556484)
2014
13
Multinodular/plexiform schwannoma of the ulnar nerve. (24165375)
2014
14
Plexiform schwannoma arising from cauda equina. (25264320)
2014
15
Plexiform schwannoma of the rectum. (23363231)
2014
16
Neuroimage: giant plexiform schwannoma of the penis. (23207604)
2013
17
Unusual intramaxillary plexiform schwannoma. (22847037)
2013
18
Plexiform schwannoma of the clitoris in a young girl: a case report. (23947092)
2013
19
Macrodactyly in the setting of a plexiform schwannoma in neurofibromatosis type 2: case report. (23453897)
2013
20
A rare case of life-threatening giant plexiform schwannoma. (22209242)
2012
21
Plexiform schwannoma of the duodenum accompanying pyloric stenosis: report of a case. (22965512)
2012
22
Plexiform Schwannoma of the nasal tip: surgical approach. (22714859)
2012
23
Multiple plexiform schwannoma of a finger. (22266205)
2012
24
Lobular breast carcinoma metastasis to a superficial plexiform schwannoma as the first evidence of an occult breast cancer. (22123192)
2011
25
A giant plexiform schwannoma of the brachial plexus: case report. (22044580)
2011
26
Plexiform schwannoma of the foot: a review of the literature and case report. (20833568)
2011
27
Giant plexiform schwannoma of the tongue. (22937374)
2011
28
Intraosseus plexiform schwannoma of the mandible: immunohistochemical differential diagnosis. (21119430)
2010
29
Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2. (20303213)
2010
30
Plexiform schwannoma of the esophagus in a child with neurofibromatosis type 2. (19573680)
2009
31
Plexiform schwannoma of the posterior tibial nerve: a case report. (19918424)
2009
32
Plexiform schwannoma in schwannomatosis. (19884750)
2009
33
Plexiform schwannoma of the lip mucosa. (19415817)
2009
34
Isolated plexiform schwannoma of the hand. (21886708)
2008
35
Cutaneous plexiform schwannoma of the finger not associated with neurofibromatosis. (18284268)
2008
36
Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region. (18439936)
2008
37
Congenital plexiform schwannoma of the clitoris. (18382807)
2008
38
Plexiform schwannoma of scalp: a case report with brief review of literature. (18306559)
2007
39
Plexiform schwannoma of the clitoris. (17614860)
2007
40
Epithelioid angiosarcoma arising in a deep-seated plexiform schwannoma: a case report and literature review. (17574948)
2007
41
Intra-extradural plexiform schwannoma of the cervical spine. (17906563)
2007
42
Plexiform schwannoma mimicking haemangioma: pitfalls in clinical diagnosis and histological interpretation. (17714565)
2007
43
Recurrent plexiform schwannoma in vestibular mucosa. (16681871)
2006
44
Contiguous conventional and plexiform schwannomas. Report of two cases. (16509508)
2006
45
Plexiform schwannoma of the ulnar nerve. (16019742)
2005
46
Multiple plexiform schwannoma of the hand and forearm: a long-term follow-up. (15950336)
2005
47
Deep-seated plexiform schwannoma: a pathologic study of 16 cases and comparative analysis with the superficial variety. (16006798)
2005
48
MR imaging features of a scalp plexiform schwannoma. (14970034)
2004
49
Plexiform schwannoma of the forearm. (14593503)
2003
50
Plexiform schwannoma. (12823295)
2003

Variations for Plexiform Schwannoma

About this section

Expression for genes affiliated with Plexiform Schwannoma

About this section
Search GEO for disease gene expression data for Plexiform Schwannoma.

Pathways for genes affiliated with Plexiform Schwannoma

About this section

Pathways related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
18.8CD34, KIT, NGFR
28.6ENO2, GFAP, NF2, NGFR

GO Terms for genes affiliated with Plexiform Schwannoma

About this section

Cellular components related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cornified envelopeGO:000153310.4CDSN, DSP
2desmosomeGO:003005710.4CDSN, DSP
3cell-cell junctionGO:000591110.0CDSN, DSP, KIT
4external side of plasma membraneGO:00098978.8CD34, KIT, NGFR

Biological processes related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cell-matrix adhesionGO:000195310.4NF1, NF2
2negative regulation of MAPK cascadeGO:004340910.4NF1, NF2
3pigmentationGO:004347310.3KIT, NF1
4intermediate filament organizationGO:004510910.2DSP, GFAP
5negative regulation of neuron projection developmentGO:001097710.0GFAP, NGFR
6regulation of cell proliferationGO:00421279.5KIT, NF1, NF2, NGFR
7single organismal cell-cell adhesionGO:00163379.0CD34, CDSN, DSP

Sources for Plexiform Schwannoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet